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This document provides guidance on practical strategies to implement antibiotic stewardship 
programs in small and critical access hospitals.1,2 It was developed as a collaboration between 
The Centers for Disease Control and Prevention, The American Hospital Association, 
The Federal Office of Rural Health Policy and The Pew Charitable Trusts.
The suggestions provided here are based on discussions with staff in small and critical access 
hospitals, several of which have implemented all of the CDC Core Elements.
Introduction
Improving antibiotic use in hospitals is imperative to improving patient outcomes. Antibiotic use 
has well known unintended consequences, including Clostridium difficile (C. difficile) diarrhea 
and other adverse events.3 C. difficile infections alone affect more than 500,000 patients and 
are associated with more than 15,000 deaths in the United States each year.4 Moreover, 
antibiotic use is an important driving factor in the growing crisis of antibiotic resistance in the 
United States. The Centers for Disease Control and Prevention (CDC) estimates that each 
year in the United States, more than 2 million patients are infected by an organism that cannot 
be treated by the recommended antibiotic and more than 20,000 of these patients die. 
Not only does antibiotic resistance threaten the well-being of patients on a daily basis, the loss 
of effective antibiotics imperils our ability to deliver life-saving medical care like surgery and 
cancer chemotherapy.
Fortunately, programs focused on improving antibiotic use or “antibiotic stewardship programs” 
have proven to be effective in mitigating these threats.5 Published evidence demonstrates 
that antibiotic stewardship programs can: improve infection cure rates and reduce C. difficile 
infections, other adverse events from antibiotics and antibiotic resistance. Furthermore, they 
achieve all of these gains while saving money.5
CDC has called on all hospitals across the country to implement antibiotic stewardship 
programs6 and the American Hospital Association has highlighted antibiotic stewardship 
as one of the ways that hospitals can more appropriately use medical resources. 
The Pew Charitable Trusts has also supported antibiotic stewardship policies and developed 
resources7 that profile how hospitals have been able to implement stewardship programs 
utilizing available resources.
To help hospitals implement and expand effective stewardship programs, in 2014, CDC released 
in 2014 “The Core Elements of Hospital Antibiotic Stewardship Programs”1 that identifies 
key structural and functional aspects of effective programs. The seven core elements were 
designed to be flexible to facilitate implementation in hospitals of any size.
Since 2014, CDC has used the National Healthcare Safety Network (NHSN) annual hospital 
survey to query hospitals about their implementation of the core elements. Results have shown 
disparities among hospital types, specifically according to bed size. In 2015, more than 50% 
of hospitals with more than 50 beds reported meeting all seven core elements compared to 26% 
of hospitals with 25 or fewer beds.
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While small and critical access hospitals face special challenges in implementing the CDC 
core elements, in part due to limitations in staffing, infrastructure and resources, antibiotic 
stewardship is no less important in these settings. Patients in small and critical access hospitals 
have not been spared the problems of antibiotic resistance and C. difficile. However, small and 
critical access hospitals also have some factors that can support improvements in care, as they 
are often tight-knit communities where collaboration is the norm. Encouragingly, over 200 critical 
access hospitals reported implementation of all seven core elements in 2015, demonstrating that 
it is feasible to implement all of the core elements in smaller hospitals.
Implementation Suggestions
Our goal is to present a range of implementation options that might be useful. Each hospital 
is unique and will need to consider which options might be most effective based on discussions 
with providers. Flexibility and tailoring approaches to local needs is essential. The options 
presented are not intended as a checklist of “must-dos.” Rather, the goal is to present options 
that might help small and critical access hospitals ensure that each of the core elements 
is in place.
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Core Elements 1 and 2: Leadership Commitment/Accountability
Leadership commitment by hospital executives and board trustees in small and critical access 
hospitals is important to ensuring allocation of the necessary resources to support antibiotic 
stewardship programs. Obtaining leadership commitment from the chief medical officer 
(CMO), pharmacy director, and nursing leaders can facilitate physician, pharmacist, infection 
preventionist, and nurse engagement to implement stewardship initiatives to create a strong 
and sustainable program.
Examples of implementation strategies:
• Designate a physician (e.g.,CMO) in the C-suite or individual that reports to C-suite 
to be accountable for the outcomes of the antibiotic stewardship program.
• Approve a policy for the creation and/or expansion of the antibiotic stewardship program 
to include all core elements.
• Integrate stewardship activities into ongoing quality improvement and/or patient safety 
efforts in the hospital (e.g., efforts to improve sepsis management)
• Create a reporting structure for the stewardship program to ensure that information 
on stewardship activities and outcomes is shared with facility leadership and the hospital 
board (e.g., semi-annual stewardship update at the board meeting).
• Issue a formal board-approved statement on the importance of the antibiotic 
stewardship program and include in the hospital’s annual report.
• Issue a statement from the hospital leadership (e.g., medical, pharmacy and nursing) 
to all providers and patients highlighting the hospital’s commitment to improving 
antibiotic use.
• Support training for hospital stewardship leaders on antibiotic stewardship through 
on-line or in-person courses.
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Some small and critical access hospitals have found it helpful to seek off-site support for their 
antibiotic stewardship efforts. Some examples include:
• Enrolling in multi-hospital, collaborative efforts to improve antibiotic use. Consider 
contacting state hospital associations, state or local public health agencies, 
and/or large academic medical centers to identity existing antibiotic stewardship 
collaboratives.
• Funding remote consultation or telemedicine with experts in antibiotic stewardship 
(e.g., infectious diseases physicians and pharmacists).
 - Even when remote expertise is used, it is important to have 
a leader of the program who is on staff at the hospital.
• Placing stewardship requirements into the contractual responsibilities of any external 
pharmacy services including a requirement that pharmacy contractors have formal 
stewardship training.
Core Element 3: Drug Expertise
In most critical access hospitals, a pharmacist, usually one who is on-site, provides the 
leadership and expertise for the antibiotic stewardship program. When possible, having 
a physician leader is helpful to support the pharmacist. Leaders of stewardship programs can 
expand their knowledge and experience through a variety of educational programs and through 
participation in multi-hospital stewardship collaboratives. External expertise via remote 
or on-site consultation has also been helpful in some critical access hospitals.
Examples of implementation strategies:
• Appoint a pharmacist leader, ideally someone who is on-site either full- or part-time. 
Consider having stewardship as part of the job description or service contract of the 
pharmacist leader and ensure that leaders have dedicated time to spend on developing 
and maintaining a stewardship program.
• Appoint a physician leader to provide physician support to the antibiotic stewardship 
program, ideally someone who is on-site either full- or part-time.
• Offer access to training courses on antibiotic stewardship to help develop local expertise.
• Seek additional expertise by joining multi-hospital improvement collaboratives 
or through remote consultation (e.g. telemedicine).
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Core Element 4: Action
There are a number of evidenced-based interventions that can improve antibiotic use. 
Decisions on which one(s) to implement should be based on local needs, which are best 
determined through discussions with providers and review of local information on antibiotic use.
The majority of all antibiotic use in hospitals is driven by just three conditions: community-
acquired pneumonia (CAP), urinary tract infections (UTIs) and skin and soft tissue infections 
(SSTIs). Studies have demonstrated a number of interventions to improve antibiotic use for 
each of these and hence these are often high-yield targets for improvement.
Studies have also shown important opportunities to stop or narrow the spectrum of therapy 
in cases where certain important and/or broad spectrum antibiotics are prescribed as initial 
therapy. Resources can be maximized by reviewing courses of therapy of certain key antibiotics 
like carbapenems, piperacillin-tazobactam and anti-MRSA agents like vancomycin. Determining 
which agents to focus on should be driven by discussions with providers. Data suggest that the 
yield of reviews is maximized when they are done after about 2 days of treatment when culture 
results are generally available. These reviews can focus on three important questions: 
Is an antibiotic still needed? If so, is the antibiotic tailored to the culture results (e.g. is the 
narrowest spectrum agent being used?) And, how long should the antibiotic be used?
The table below summarizes some of the key areas where studies and guidelines suggest 
important opportunities to improve antibiotic use. Ideally, treatment decisions should be driven 
by local data on antibiotic resistance. If local antibiograms are unavailable, consider using 
regional resistance data. Many critical access hospitals have found it most useful and efficient 
to adapt antibiotic treatment recommendations from nearby hospitals, collaborative efforts 
or from on-line resources. Adoption of recommendations can be enhanced by requiring 
an indication for therapy when antibiotics are ordered and by embedding recommendations 
in computer order entry systems where possible.
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TABLE 1. KEY OPPORTUNITIES TO IMPROVE ANTIBIOTIC USE








Review cases at 48 hours to confirm 
pneumonia diagnosis versus 
non-infectious etiology.
Avoid empiric use of antipseudomonal 
beta-lactams and/or methicillin-resistant 




in most cases, 
uncomplicated 
pneumonia 
can be treated 
for 5-7 days 
in the setting 





Implement criteria for ordering urine 
cultures to ensure that positive cultures 
are more likely to represent infection, 
rather than bladder colonization.
Examples include:
- Only order a urine culture if the patient 
has signs and symptoms consistent 
with UTI such as urgency, frequency, 
dysuria, suprapubic pain, flank pain, 
pelvic discomfort and acute hematuria.
- For patients with urinary catheters, 
avoid culturing urine based solely 
on cloudy appearance or foul smell 
in the absence of signs and symptoms 
of UTI. Non-specific signs and 
symptoms such as delirium, nausea, 
vomiting should be interpreted with 
caution as by themselves they have 
a low specificity for UTI. 
Establish criteria to distinguish between 
asymptomatic and symptomatic 
bacteriuria. Avoid antibiotic therapy 
for asymptomatic bacteriuria except 
in certain clinical situations where 
treatment is indicated, such as for 
pregnant women and those undergoing 
an invasive genitourinary procedure.









Skin and soft tissue 
infections12
Develop diagnostic criteria to distinguish 
purulent and non-purulent infections and 
severity of illness (i.e., mild, moderate 
and severe) so that skin and soft tissue 
infections can be managed appropriately 
according to guidelines.
Avoid empiric use of antipseudomonal 
beta-lactams and/or anti-anaerobic 
agents unless clinically indicated. 
Guidelines 
suggest that 





for 5 days 




Small and Critical Access Hospitals   7
There are also key stewardship actions that can be implemented by other team members 
in small and critical access hospitals. Indeed, experts working on stewardship in these hospitals 
emphasize the value of a team-based approach.
• The following items are daily activities that can also be performed by a pharmacist:
 - Review antibiotics for unnecessary duplicative antibiotic therapy, such as double 
anaerobic (e.g., piperacillin/tazobactam AND metronidazole) or double anti-MRSA 
coverage.
 - Review for opportunities for intravenous to oral conversion (e.g. patients taking other 
oral medications).
 - Monitor for medication safety (e.g., renal dose adjustments) though these represent 
general pharmacy practices and are not specific to stewardship.
• Nurses play an important role in implementing stewardship actions in critical access 
hospitals.13 For example, nurses can:
 - Review culture techniques to ensure that microbiology cultures are collected 
properly.
 - Review culture results with the treating clinician and pharmacist.
 - Monitor response to antibiotic therapy with feedback to the treating clinician 
and pharmacist.
 - Assess oral intake and clinical status to alert providers and pharmacist when there 
are opportunities to convert antibiotics from intravenous to oral therapy.
 - Educate patients about potential adverse events associated with antibiotics, 
especially C. difficile infection.
 - Nurses are also well positioned to initiate “antibiotic time-outs” with the treating 
clinician and pharmacist, and review antibiotic therapy after 48 hours of treatment.
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Core Element 5: Tracking
Data are essential for informing and assessing stewardship actions. A variety of data options 
are outlined below, and some hospitals might also have more individualized measures. Small 
and critical access hospitals can review options and make decisions based on local needs 
and resources. The ultimate key is to have a measure that is useful for stewardship activities, 
meaningful to providers and that can be tracked over time to assess improvements.
Days of therapy is considered the most useful measure of antibiotic use to inform stewardship 
efforts. Facilities can electronically capture, analyze and benchmark days of therapy through 
the CDC’s National Healthcare Safety Network (NHSN) Antimicrobial Use (AU) Option.14 
Tracking adherence to treatment recommendations and performance of interventions such 
as antibiotic time-outs can be useful to further guide quality improvement efforts. In addition, 
small and critical access hospitals are well positioned to monitor antibiotic use at the provider 
level. This type of individual-level feedback can be very helpful. Stewardship programs can work 
with infection control programs to track data on C. difficile and antibiotic-resistant infections. 
Finally, antibiotic expenditures should not be used as a way to track the effectiveness 
of stewardship efforts as antibiotic expenditures do not always correlate with antibiotic use.
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Examples of implementation strategies:
• Submit antibiotic use and resistance through CDC NHSN AU and Resistance Module.
 - Alternative approach (if NHSN AU Option not feasible): Calculate defined daily dose 
(DDD) per WHO ATC DDD Guidelines15 for top 5 commonly used antibiotics 
(e.g., ceftriaxone, azithromycin, vancomycin, piperacillin-tazobactam, and 
fluoroquinolones).This can be useful in tracking antibiotic use over time at a given 
hospital. Note that the DDD metric has limitations in pediatrics.16
• Monitor adherence to facility-specific treatment recommendations (see above 
in Action) for CAP, UTI and SSTI. If feasible, consider tracking adherence to treatment 
recommendations per provider.1
• Monitor the performance of antibiotic time-outs to see how often these are being done 
and if opportunities to improve use are being realized during time-outs.
• Perform a medication use evaluation to assess courses of therapy for selected 
antibiotics (e.g., piperacillin-tazobactam, carbapenems, vancomycin, fluoroquinolones) 
to see if there are opportunities to improve use.
• Monitor how often patients are converted from intravenous to oral therapy and assess 
to see if there are missed opportunities to convert.
• Assess how often patients are prescribed unnecessary duplicate therapy (e.g., two 
antibiotics to treat anaerobes).
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Core Element 6: Reporting
The reporting for critical access hospitals should be consistent with the action and tracking 
components of the antibiotic stewardship program (e.g., optimizing diagnosis and treatment 
for the commonly encountered infections, reducing unnecessary duplicate therapy, etc). 
As mentioned above, data on stewardship efforts should be reported not just to providers, but 
also to the hospital leadership and board. A key to success is to discuss reporting options 
with stakeholders to determine optimal timing, format and delivery method(s) for the reports.
Examples of implementation strategies:
• Prepare regular reports on the measures being tracked related to antibiotic use. 
Include these data as a standing report to key stakeholders within the facility, e.g., 
pharmacy and therapeutics, patient safety/quality, medical staff leadership/committees, 
and hospital board.
• If feasible, share provider-specific reports with individual clinicians confidentially.
• Distribute data and key messaging through staff newsletters and emails.
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Core Element 7: Education
The limited number of providers, along with the collaborative nature of many small and critical 
access hospitals, create some unique advantages for providing individualized education 
compared to larger hospitals. The pharmacist and/or physician leader can provide stewardship 
education (e.g., optimizing diagnosis and treatment for the commonly encountered infections, 
reducing unnecessary duplicate therapy, etc.) to individual providers and pharmacists. Specific 
education for nurses could also be very helpful, for example, criteria for intravenous to oral 
conversion, optimal technique for culture collection, and criteria for when to obtain a urine 
culture. Lastly, patient and family education can also help drive improvements in antibiotic 
use and empower patients and families to help monitor for important adverse events, like 
C. difficile infection. To help with patient and family education, the CDC developed a fact sheet 
on antibiotic use for hospitalized patients.17
Examples of Implementation Strategies:
• Integrate regular (e.g., monthly or at least quarterly) updates on antibiotic stewardship 
and resistance into communications tools with particular focus on interventions related 
to CAP, UTI and SSTI (e.g., blogs, website, intranet, and employee newsletters).
• Provide targeted in-person or web-based educational presentations and messages 
to key provider, pharmacist and nursing groups at least annually (e.g., staff meetings 
for sections).
• One-on-one provider education/coaching (e.g., academic detailing).
• Incorporate antibiotic stewardship education into orientation for new medical, 
pharmacist and nursing staff and required annual provider educational programs.
• Incorporate antibiotic stewardship into (re)credentialing education
• Ask the patient-family advisory committee for input on patient education material.
• Develop stories to share how patients’ lives are affected by complications of antibiotic 
use (e.g. C. difficile infection).
• Include information on antibiotics in patient education materials.
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Appendix: Additional Resources for Antibiotic 
Stewardship Programs (that are not part of text)
General Resources
• The National Quality Partners Playbook: Antibiotic Stewardship in Acute Care: 
Comprehensive list of suggested tools and resources for each core element for antibiotic 
stewardship.
• Joint Commission Resources. Regulatory and Accreditation Requirements
Certificate Training Programs
• Making a Difference in Infectious Diseases (MAD-ID) Antimicrobial Stewardship 
Certificate Training Program.
• Society of Infectious Diseases Pharmacists (SIDP) Antimicrobial Stewardship 
Certificate Training Program.
Implementation Tools
• Centers for Disease Control and Prevention (CDC) and The Pew Charitable Trusts. 
Strategies to assess antibiotic use to drive improvements in hospitals
• EQuIP (Education, Quality, Infection Prevention, Training, and Professional Development 
Program). Jump Start Stewardship. Implementing Antimicrobial Stewardship 
in a Small Rural Hospital.
• Kansas Department of Health and Environment. Antimicrobial Stewardship Programs 
a Toolkit for Critical Access Hospitals in Kansas.
• The Society for Healthcare Epidemiology of America. Antimicrobial stewardship: 
Implementation tools & resources.
Tracking and Reporting:
• Centers for Disease Control and Prevention (CDC). Multidrug-Resistant Organism 
& Clostridium difficile Infection module. Atlanta, GA: CDC; 2017.
• Society of Infectious Diseases Pharmacists (SIDP). Software vendors who support 
the CDC Antimicrobial Use and Resistance Initiative.
Education:
• CDC Get smart about antibiotics week website.
